# PPI Test in GP Patients

> **NCT00318084** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 100 (—)

## Conditions studied

- GERD

## Interventions

- **DRUG:** Esomeprazole
- **PROCEDURE:** Ambulatory 24-hour esophageal pH-monitoring

## Key facts

- **NCT ID:** NCT00318084
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (—)
- **Last updated:** 2007-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318084, "PPI Test in GP Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00318084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*